Minimal Residual Disease, Metastasis and Immunity

Minimal Residual Disease, Metastasis and Immunity

Progression from localized to metastatic disease requires cancer cells spreading to distant organs through the bloodstream. Only a small proportion of these circulating tumor cells (CTCs) survives dissemination due to anoikis, shear forces and elimination by the immune system. However, all metastase...

Full description

Bibliographic Details
Main Authors:	Jordi Badia-Ramentol, Jenniffer Linares, Andrea Gómez-Llonin, Alexandre Calon
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Biomolecules
Subjects:	CTC DTC MRD dormancy immunity metastasis
Online Access:	https://www.mdpi.com/2218-273X/11/2/130

Similar Items

Dynamics of Minimal Residual Disease in Neuroblastoma Patients
by: Suguru Uemura, et al.
Published: (2019-06-01)

Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood
by: Kyaw San Lin, et al.
Published: (2021-08-01)

Integrated EpCAM‐independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells
by: Peter Ping Lin
Published: (2015-12-01)

The covert symphony: cellular and molecular accomplices in breast cancer metastasis
by: Hongjiang Si, et al.
Published: (2023-06-01)

The critical role of platelet in cancer progression and metastasis
by: Lin Zhou, et al.
Published: (2023-09-01)

Network approach in liquidomics landscape
by: Daniele Santini, et al.
Published: (2023-08-01)

Harnessing Minimal Residual Disease as a Predictor for Colorectal Cancer: Promising Horizons Amidst Challenges
by: Xiaofen Wen, et al.
Published: (2023-10-01)

Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature
by: Zeinab S. Sayed, et al.
Published: (2024-04-01)

Detection of Circulating and Disseminated Tumor Cells and Their Prognostic Value under the Influence of Neoadjuvant Therapy in Esophageal Cancer Patients
by: Florian Richter, et al.
Published: (2022-03-01)

Tumor Dormancy: Implications for Invasion and Metastasis
by: Georgia Gomatou, et al.
Published: (2021-05-01)

EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
by: Anthony Genna, et al.
Published: (2020-06-01)

MRD-Nets: Multi-Scale Residual Networks With Dilated Convolutions for Classification and Clustering Analysis of Spacecraft Electrical Signal
by: Yixin Liu, et al.
Published: (2019-01-01)

Remodeling the ECM: Implications for Metastasis and Tumor Dormancy
by: Julie S. Di Martino, et al.
Published: (2021-09-01)

HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
by: Svenja Schneegans, et al.
Published: (2024-04-01)

Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
by: O'Sullivan HM, et al.
Published: (2023-04-01)

Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
by: David Foureau, et al.
Published: (2021-10-01)

Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts
by: Mathias Chea, et al.
Published: (2024-02-01)

Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
by: Lemei Zhu, et al.
Published: (2023-08-01)

Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection
by: Burnusuzov Hasan A., et al.
Published: (2016-03-01)

Detection of Circulating Tumor Cells Using the Attune NxT
by: Mandy Gruijs, et al.
Published: (2022-12-01)

Applications of RNA characterisation in circulating tumour cells
by: Sara Hassan, et al.
Published: (2020-01-01)

Enhancement of the Direct Torque Control by using Artificial Neuron Network for a Doubly Fed Induction Motor
by: SAID MAHFOUD, et al.
Published: (2022-01-01)

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
by: Cumbo C, et al.
Published: (2020-05-01)

Multipoint Costriking Nanodevice Eliminates Primary Tumor Cells and Associated‐Circulating Tumor Cells for Enhancing Metastasis Inhibition and Therapeutic Effect on HCC
by: Weiwei Mu, et al.
Published: (2022-03-01)

Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
by: Jenniffer Linares, et al.
Published: (2021-01-01)

Late Cutaneous Metastasis Originating from Gastric Cancer with Synchronous Metastasis
by: Ryota Koyama, et al.
Published: (2019-02-01)

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia
by: Azza M. Kamel, et al.
Published: (2022-04-01)

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
by: Letitia-Elena Radu, et al.
Published: (2020-06-01)

The Role of the Innate Immune System in Cancer Dormancy and Relapse
by: Noah M. Chernosky, et al.
Published: (2021-11-01)

Minimal residual disease negativity by next‐generation flow in non‐CR myeloma patients
by: Sung‐Min Kim, et al.
Published: (2020-11-01)

Technologies for Viable Circulating Tumor Cell Isolation
by: Maria S. Tretyakova, et al.
Published: (2022-12-01)

Update on the role of circulating tumour cells in cancer-associated thrombosis
by: John Castle, et al.
Published: (2021-12-01)

Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
by: Chong Gao, et al.
Published: (2019-01-01)

CÉLULAS TUMORALES CIRCULANTES EN LA PRÁCTICA ONCOLÓGICA: IMPORTANCIA EN TUMORES SÓLIDOS EPITELIALES
by: Luz Fernanda Sua Villegas, et al.
Published: (2011-04-01)

A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells
by: Aleksandra Śliwa, et al.
Published: (2024-02-01)

Minimal residual disease (MRD) detection with translocations and T-cell receptor and immunoglobulin gene rearrangements in adult acute lymphoblastic leukemia patients: a pilot study
by: Muge Sayitoglu, et al.
Published: (2008-09-01)

Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells
by: Luigi Ombrato, et al.
Published: (2020-11-01)

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
by: Arnaud Pigneux, et al.
Published: (2018-11-01)

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial
by: Elisabeth K. Trapp, et al.
Published: (2022-08-01)

Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2020-07-01)